EMAPALUMAB
UNII 3S252O2Z4X

Substance Identification & Data

This profile provides standardized clinical and technical data for Emapalumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3S252O2Z4X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1709815-23-5 and the RxNorm Concept ID (RxCUI) 2104604. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3S252O2Z4X

CAS Registry Number

1709815-23-5

RxNorm Concept ID

2104604

Detailed Substance Profile

Preferred Name

EMAPALUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

3S252O2Z4X

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C127123

National Cancer Institute reference terminology for clinical and research data.

INN ID

10319

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-170

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emapalumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.